motapizone has been researched along with colforsin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmann, A; Klöcking, HP | 1 |
| Dent, G; Magnussen, H; Nakashima, M; Rabe, KF; Schudt, C; Tenor, H | 1 |
2 other study(ies) available for motapizone and colforsin
| Article | Year |
|---|---|
Inhibition of thrombin-induced tissue-type plasminogen activator release by agents which increase intracellular cyclic AMP.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Colforsin; Cyclic AMP; Ear, External; In Vitro Techniques; Milrinone; Perfusion; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Solutions; Swine; Thrombin; Tissue Plasminogen Activator | 1990 |
Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Aged; Antihypertensive Agents; Carbachol; Colforsin; Cytosol; Dinoprost; Dose-Response Relationship, Drug; Female; Humans; Isoenzymes; Kinetics; Lung Neoplasms; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pulmonary Artery; Purinones; Pyridazines; Pyrrolidinones; Rolipram | 1994 |